The lipopeptides Pal-Lys-Lys-NH2 and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection

Peptides

Volumn 28, Issue 6, 2007, Pages 1299-1303

  Cirioni, Oscar ^a   Giacometti, Andrea ^a   Ghiselli, Roberto ^a   Kamysz, Wojciech ^b   Silvestri, Carmela ^a   Orlando, Fiorenza ^c   Mocchegiani, Federico ^a   Vittoria, Agnese Della ^a   Kamysz, Elzbieta ^d   Saba, Vittorio ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c INRCA   (Italy)

^d UNIVERSITY OF GDA SK   (Poland)

Author keywords

Antimicrobial peptides; Bacterial biofilm; Lipopeptides; Vascular graft infection

Indexed keywords

LIPOPEPTIDE; PALMITOYLLYSYLLYSYLAMIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIOFILM; BLOOD VESSEL GRAFT; COLONY FORMING UNIT; DRUG EFFICACY; DRUG MECHANISM; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUBCUTANEOUS TISSUE; ULTRASOUND;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; IMPLANTS, EXPERIMENTAL; INJECTIONS, INTRAPERITONEAL; MALE; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; PROSTHESIS-RELATED INFECTIONS; RATS; RATS, WISTAR; STAPHYLOCOCCAL SKIN INFECTIONS; SUBCUTANEOUS TISSUE; VANCOMYCIN;

BACTERIA (MICROORGANISMS); RATTUS; RATTUS NORVEGICUS; STAPHYLOCOCCUS AUREUS;

EID: 34249687600     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.03.017     Document Type: Article

References (30)

1. Ammendolia M.G., Rosa R.D., Montanaro L., Arciola C.R., and Baldassarri L. Slime production and expression of slim-associated antigen by staphylococcal clinical isolates. J Clin Microbiol 37 (1999) 3235-3238
2. Avrahami D., and Shai Y. A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J Biol Chem 279 (2004) 12277-12285
3. Bergamini T.M., Corpus Jr. R.A., McCurry T.M., Peyton J.C., Brittian K.R., and Cheadle W.G. Immunosuppression augments growth of graft-adherent Staphylococcus epidermidis. Arch Surg 130 (1995) 1345-1350
4. Christensen G.D., Simpson W.A., Younger J.J., Baddour L.M., Barrett F.F., Melton D.M., et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22 (1985) 996-1006
5. Cirioni O., Giacometti A., Ghiselli R., Bergnach C., Orlando F., Mocchegiani F., et al. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides 27 (2006) 2104-2110
6. Cirioni O., Giacometti A., Ghiselli R., Dell'Acqua G., Orlando F., Mocchegiani F., et al. RNAIII inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated S. aureus infections. J Infect Dis 193 (2006) 180-186
7. Cirioni O., Silvestri C., Ghiselli R., Giacometti A., Orlando F., Mocchegiani F., et al. Experimental study on the efficacy of combination of α-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. Peptides 27 (2006) 2600-2606
8. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilm: a common cause of persistent infections. Science 284 (1999) 1318-1322
9. Donlan R.M., and Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2002) 167-193
10. Douglas J.L., and Cobbs C.G. Prostethic valve endocarditis. In: Kaye D. (Ed). Infective endocarditis (1992), Raven Press Ltd., New York, NY 375-396
11. Epand R.M., and Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462 (1999) 11-28
12. Gabay J.E. Ubiquitous natural antibiotics. Science 264 (1994) 373-374
13. Goeau-Brissonniere O.A., Fabre D., Leflon-Guibout V., Di Centa L., Nicolas-Chanoine M.H., and Coggia M. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg 35 (2002) 1260-1263
14. Hall-Stoodley L., Costerton J.W., and Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2 (2004) 95-108
15. Hancock R.E.W. Artificial valve disease. In: Schlant R.C., Alexander R.W., O'Rourke R.A., Roberts R., and Sonnenblick E.H. (Eds). The heart arteries and veins (1994), McGraw-Hill Inc., New York, NY 1539-1545
16. Hancock R.E.W. Peptides antibiotics. Lancet 349 (1997) 418-422
17. Hancock R.E.W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1 (2001) 156-164
18. Harvey R.A., Alcid D.V., and Greco R.S. Antibiotic bonding to polytetrafluoroethylene with tridodecylmethylammonium chloride. Surgery 92 (1982) 504-512
19. Henke P.K., Bergamini T.M., Rose S.M., and Richardson J.D. Current opinion in prosthetic vascular graft infection. Am Surg 64 (1998) 39-45
20. Kamysz W., Kochańska B., Ke{ogonek}dzia A., Ochocińska J., Maćkiewicz Z., Kupryszewski G., et al. SV2 and its analogue. Synthesis and evaluation of antimicrobial activity. Pol J Chem 76 (2002) 801-806
21. 2 and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant Gram-positive cocci. Antimicrob Agents Chemother 51 (2007) 354-358
22. Mah T.F., and O'Toole G.A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9 (2001) 34-39
23. Maki D.G. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention and management. In: Bisno A.L., and Waldovogel F.A. (Eds). Infections associated with indwelling medical devices (1994), American Society for Microbiology, Washington, DC 155-212
24. Malina A., and Shai Y. Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide. Biochem J 390 (2005) 695-702
25. Gara O., and Humphreys J.P. H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 50 (2001) 582-587
26. Phaneuf M.D., Quist W.C., Bide M.J., and LoGerfo F.W. Modification of the polyethylene terephthalate (Dacron) via denier reduction: effects on material tensile strength, weight, and protein binding capabilities. J Appl Biomater 6 (1995) 289-299
27. Raad I., Alrahwan A., and Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 26 (1998) 1182-1187
28. Sago T., Mori Y., Takagi H., Iwata H., Murase K., Kawamura Y., et al. Local treatment of dacron patch graft contaminated with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic: an experimental study in the rabbit. J Vasc Surg 37 (2003) 169-174
29. Stepanovic S., Vukovic D., Dakic I., Savic B., and Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40 (2000) 175-179
30. Stewart P.S., and Costerton J.W. Antibiotic resistance of bacteria biofilm. Lancet 358 (2001) 135-138